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The structure of adenylosuccinate lyase, an enzyme with dual
activity in the de novo purine biosynthetic pathway
Eric A Toth1 and Todd O Yeates1,2*
Background: Adenylosuccinate lyase is an enzyme that plays a critical role in
both cellular replication and metabolism via its action in the de novo purine
biosynthetic pathway. Adenylosuccinate lyase is the only enzyme in this
pathway to catalyze two separate reactions, enabling it to participate in the
addition of a nitrogen at two different positions in adenosine monophosphate.
Both reactions catalyzed by adenylosuccinate lyase involve the β-elimination of
fumarate. Enzymes that catalyze this type of reaction belong to a superfamily,
the members of which are homotetramers. Because adenylosuccinate lyase
plays an integral part in maintaining proper cellular metabolism, mutations in the
human enzyme can have severe clinical consequences, including mental
retardation with autistic features. 
Results: The 1.8 Å crystal structure of adenylosuccinate lyase from Thermotoga
maritima has been determined by multiwavelength anomalous dispersion using
the selenomethionine-substituted enzyme. The fold of the monomer is reminiscent
of other members of the β-elimination superfamily. However, its active tetrameric
form exhibits striking differences in active-site architecture and cleft size.
Conclusions: This first structure of an adenylosuccinate lyase reveals that,
along with the catalytic base (His141) and the catalytic acid (His68), Gln212
and Asn270 might play a vital role in catalysis by properly orienting the succinyl
moiety of the substrates. We propose a model for the dual activity of
adenylosuccinate lyase: a single 180° bond rotation must occur in the substrate
between the first and second enzymatic reactions. Modeling of the pathogenic
human S413P mutation indicates that the mutation destabilizes the enzyme by
disrupting the C-terminal extension.
Introduction
Adenylosuccinate lyase (ASL) catalyzes two similar but
separate reactions in the de novo purine biosynthesis
pathway. In the first reaction ASL converts 5-aminoimida-
zole-(N-succinylocarboxamide) ribotide (SAICAR) into
5-aminoimidazole-4-carboxamide ribotide (AICAR) [1]
(Figure 1). This is the ninth step in the portion of the
pathway that affords the de novo synthesis of inosine
monophosphate (IMP). In the second reaction ASL con-
verts adenylosuccinate into adenosine monophosphate
(AMP). This reaction occurs four steps after the previous
ASL-catalyzed reaction. 
The purine biosynthesis pathway provides the majority of
purine nucleotides needed for cellular replication. The
rest are provided via nucleotide salvage pathways. In addi-
tion to its role in replication, ASL participates, along with
adenylosuccinate synthetase and AMP deaminase, in the
purine nucleotide cycle [2]. The purine nucleotide cycle
aids in the tight regulation of cellular metabolism by con-
trolling both the amounts of available citric acid cycle
intermediates and the amount of free AMP (which affects
the rate of formation of adenosine triphosphate [ATP] by
adenylate kinase). Thus, ASL plays a major role in both
cellular replication and metabolism. 
Both reactions catalyzed by ASL involve the β-elimination
of fumarate via a general base–general acid mechanism. In
this mechanism the general base abstracts a methylene
proton from the carbon in the β position relative to the
leaving nitrogen (Figure 1). This occurs in concert with
general acid catalysis in which another proton is donated
to the leaving nitrogen, causing scission of the C–N bond.
Recent affinity-labeling studies of Bacillus subtilis ASL
[3,4] have demonstrated that in all likelihood the two
residues participating in this general acid–general base
mechanism are His68 and His141. These residues share
identical numbering in T. maritima ASL. Subsequent
mutagenesis and kinetic studies [5] have shown that
His141 functions as the general base and His68 as the
general acid. In addition, intersubunit complementation
experiments with His141 and His68 mutants have shown
that the active site is formed from more than one subunit
in the tetrameric enzyme [5].
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ASL belongs to a superfamily of enzymes that catalyze
β-elimination reactions. Other members of the superfam-
ily include aspartase [6], fumarase [7], argininosuccinate
lyase [8], δ-crystallin [9], and 3-carboxy-cis,cis-muconate
lactonizing enzyme [10]. All are homotetramers with D2
symmetry and molecular weights of approximately
200 kDa. With the addition of ASL, the three-dimensional
(3D) structures of all but the lactonizing enzyme have now
been determined. Sequence identity between diverse
members of the superfamily is typically less than 25%.
However, as expected from the similarity of their func-
tions, the crystal structures of these enzymes show that
the proteins have similar 3D folds.
As the participation of ASL in the purine nucleotide cycle
has a profound effect on metabolism in the brain and
muscles [2], deficiency of ASL activity can have adverse
clinical effects including muscle wasting, psychomotor
retardation, and mental retardation with autistic features.
The link between autistic features and ASL deficiency
was first established when the presence of elevated levels
of dephosphorylated derivatives of SAICAR and adenylo-
succinate were detected in the blood of children display-
ing autistic features [11]. Some of these children
accumulated 150–500 µM levels of succinyladenosine and
SAICA riboside in their blood, whereas in normal subjects
the levels of these compounds in the blood were below
the limit of detectability (<1 µM). Several point mutations
in ASL have been identified that are associated with defi-
ciency of enzymatic activity and either psychomotor retar-
dation or autistic features [12–14]. 
One pathogenic mutation, S413P (single-letter amino
acid code), seems to be solely structural in nature. The
mutant enzyme has identical kinetic properties to the
wild-type enzyme but is less stable when subjected to
guanadinium hydrochloride, urea or thermal denatura-
tion. Levels of the ASL mutant in lymphoblasts of
affected individuals are lower than the levels of wild-type
enzyme in the lymphoblasts of unaffected individuals,
suggesting that this particular mutation leads to a higher
susceptibility to proteolytic degradation [13].
Here, we report the first structure of an adenylosuccinate
lyase. The 1.8 Å resolution structure of ASL from the
thermophilic eubacterium T. maritima allows us to supple-
ment the current biochemical data about the active site
and mechanism. In addition, we can explain the dual
activity that makes ASL unique not only among enzymes
in the purine biosynthetic pathway but also among
members of the β-elimination superfamily. Finally, the
current model illuminates the effect of the most carefully
studied pathogenic human ASL mutation, S413P.
Results and discussion
The T. maritima ASL monomer and tetramer
Much like the other enzymes in the β-elimination super-
family, the T. maritima ASL monomer contains three
domains that are arranged to form a long, kinked structure
akin to a question mark (Figure 2a). Domain 1 includes
residues 1–93, domain 2 contains residues 94–349, and
domain 3 contains residues 350–431. Domain 1 is compact,
entirely α-helical, and contains helices 1–7. The putative
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Figure 1
Reactions catalyzed by ASL in purine
biosynthesis. During catalysis, one proton is
abstracted from the boxed methylene
while another proton is donated to the
leaving nitrogen.
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catalytic acid, His68, is located on the loop between helices
5 and 6. In contrast, domain 2 is far more elongated, contain-
ing a bundle of five α helices and the only β-sheet structure
in the monomer. Strands 1 and 2 protrude from helices 8
and 9, positioning the putative catalytic base, His141, in the
active site. Strand 3 follows helix 9 and the subsequent short
helix 10 places strand 4 next to strand 3. The core of the
tetramer is formed from the long helices (8, 9, and 11–14)
that comprise the majority of domain 2. The transition
between domains 2 and 3 is made by the short helix 15.
Domain 3 is mostly compact (except for helix 22), and like
domain 1 is entirely helical. Helices 16–20 make up consec-
utive helix-turn-helix motifs and lead into the C-terminal
extension, which is composed of helices 21 and 22. This
extension packs against helices 8 and 9 of domain 2.
Because ASL is inactive at the low pH (4.5) under which
the selenomethionine-substituted enzyme was crystallized,
we have also determined the structure of the native enzyme
at a pH favoring enzyme activity (9.0). Although the overall
disparity between the two models is minimal (0.42 Å root
mean square deviation [rmsd] between the 423 Cα pairs),
there is one important change induced by a difference in
pH between the two crystal forms. His68, which should be
fully protonated at pH 4.5, has its δ nitrogen within hydro-
gen-bonding distance (3.25 Å) of the carbonyl oxygen of
Thr66. In the native model, however, the imidazole ring of
His68 has moved far away from the carbonyl oxygen of
Thr66. The orientation of His68 at low pH would have pre-
cluded the manual docking studies discussed below. The
substrate was modeled into the native (high pH) form. The
relevance of the observed conformational change is not
clear at this time. Experimental determination of the pKa
values for the catalytic acid and base indicates that the pKa
of the general acid in T. maritima ASL is 9.3 (data not
shown). Therefore, His68 should be mostly protonated
even at pH 9.0, indicating that the high-pH model repre-
sents a catalytically active species.
Four of the above monomers come together to form a
tetramer with D2 symmetry. Four copies of domain 2 form
the elongated bundle of 20 α helices in the core of the
tetramer. Two copies of domain 3 sit at the top and
bottom (as viewed in Figure 2b) of the elongated
tetramer. The active-site cleft is formed by the intersec-
tion of three separate subunits and can be clearly seen in
Figures 2b and c. In Figure 2c, domains 1 and 2 of
monomer 2 (residues 19–93, 176–222, and 288–313),
domain 2 of monomer 3 (residues 237–257 and 263–283),
and domains 2 and 3 of monomer 4 (residues 136–151 and
339–430) all contribute to the active site.
Structure superposition of T. maritima ASL, fumarase C,
and δ-crystallin
ASL is a member of a superfamily of enzymes that elimi-
nate fumarate from substrates ranging in size from adenylo-
succinate to malate. Despite the fact that the enzymes in
this superfamily perform reactions involving similar chem-
istry, the sequence identity among members of the family
is typically below 25%. However, the 3D structures of
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Figure 2
The ASL monomer and its individual domains, and the ASL tetramer.
(a) The ASL monomer with its domains color coded: domain 1 is
colored red, domain 2 yellow, and domain 3 blue. (b) The T. maritima
ASL tetramer. Coloring is the same as in (a), with monomer 4 shown in
green. (c) The T. maritima ASL tetramer with one active site colored
according to which monomer contributes to that site. The color
scheme is the same as in (b). This figure was generated using
RIBBONS [36]. Individual panels are not shown to scale.
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these molecules reveal their basic similarities. The pro-
teins all form tetramers with four active-site clefts, each
formed by three distinct subunits. In order to highlight
the similarities and differences between proteins in this
superfamily we superimposed the 3D structures of
fumarase C [7], δ-crystallin [9], and ASL. 
It is apparent from the structural alignments between the
members of the superfamily that the core (domain 2) is
highly conserved (Figure 3). In contrast, domains 1 and 3
diverge significantly across the superfamily. Domain 1 of
fumarase C has additional secondary structure units at its
N terminus. As a result, this domain 1 has a different topol-
ogy from those of ASL and δ-crystallin. In addition, we
observe significantly different rigid-body orientations of
domains 1 and 3 (Figure 3). This was quantified by com-
paring the results of structural alignments conducted with
intact monomeric proteins versus structural alignments
with isolated domains. In the alignments of domain 1 and
domain 3 a small rotation and translation significantly
improves the overlap between these domains in ASL and
the corresponding domains in fumarase C and δ-crystallin. 
The effects of the rigid-body displacements of domains 1
and 3 on the size and shape of the active-site clefts of the
three enzymes can be seen in Figure 4. The active-site cleft
of ASL is by far the deepest and widest (Figure 4a), as one
would expect is necessary to provide access to its bulky,
charged substrates. In contrast, the active-site cleft of
fumarase C, which has the smallest substrate, is far narrower
and not as deep (Figure 4b). In addition to the effects of
altered domain orientations, the active-site cleft of fumarase
C is further contracted by the presence of the additional
β structure at its N terminus. The active site of δ-crystallin
(an eye-lens protein that has evolved from argininosuccinate
lyase) is partly occluded by residue contacts on its front face
(Figure 4c). When viewed from another angle, a cleft can be
observed that is larger than that of fumarase C but still
smaller than the cleft of ASL (Figure 4d). It seems that evo-
lution has conferred, in part via these rigid-body changes,
open states that afford access to substrates that vary greatly
in size. The rigid-body adjustment of domain 1 might also
affect the position of the catalytic acid in the three enzymes.
The active site and mechanistic implications
The active-site picture obtained by the current work on
ASL is incomplete. Without a bound inhibitor or substrate
analog, the specific contacts made by the enzyme to its two
substrates cannot be analyzed in detail. However, both bio-
chemical and multiple sequence alignment data, along with
structural comparisons to other enzymes in the β-elimina-
tion superfamily, can give useful information about the
residues involved in substrate binding and catalysis in ASL.
In order to assist in the mechanistic analysis of ASL, the
substrate adenylosuccinate was placed by visual inspection
in one active-site cleft (formed from monomers 2, 3, and 4 of
the tetramer) of ASL. It is possible to place the substrate in
such an orientation that the β carbon of the succinyl moiety
(C21 in Figure 5a) is close to the general base (His141) con-
tributed by monomer 4, and the amide nitrogen of the
leaving group AMP (N15 in Figure 5a) is within hydrogen-
bonding distance of the general acid (His68) contributed by
monomer 2. In addition, affinity labeling with 2-[(4-bromo-
2,3-dioxybutyl)thio]adenosine 5′-monophosphate (2BDB-
TAMP) indicates which part of the purine ring (indicated
by a red asterisk in Figure 5a) should be near to His68.
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Figure 3
Structural alignment statistics for ASL,
fumarase C, and δ-crystallin. The reported
numbers are the rmsds between
corresponding Cα atoms. The number of Cα
pairs involved in the alignment is shown in
parentheses. Domains 1, 2, and 3 are
abbreviated as D1, D2, and D3, respectively.
*Domain 1 or 3 aligned as an individual unit.
†Motion that occurs upon alignment of domain
1 or 3 as an individual unit.
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These restrictions, which are imposed by the current bio-
chemical data, define the orientation of adenylosuccinate in
the active site of ASL with sufficient precision to highlight
individual residues other than His68 and His141 that might
be involved in substrate binding and catalysis. Without
additional biochemical or structural data it is impossible to
determine with confidence the detailed interactions with
the sugar phosphate of adenylosuccinate. The only required
adjustment to the protein conformation was a small rotation
about χ2 of His68 to eliminate an unreasonably close contact
between the Cδ2 of His68 and the purine ring of adenylosuc-
cinate. Energy minimization of this model using the
program CNS [15] caused no significant changes, indicating
that it is energetically reasonable. Because of the cavernous
nature of the active-site cleft of ASL, computational
docking programs [16,17] failed to identify a unique docked
conformation for adenylosuccinate. However, of the many
possible solutions produced, several have conformations
that closely resemble the proposed model.
The contacts made between ASL and adenylosuccinate in
this model seem to be consistent with the chemistry of the
groups in the active site, multiple sequence alignment
data, and data from superimposing the structures of ASL,
fumarase C, and δ-crystallin. The catalytic base, His141,
forms a charge-relay pair with Glu275 that would help
abstract a proton from the substrate. Multiple sequence
alignment data indicate that these two residues are
absolutely conserved among the entire superfamily of
enzymes (Figure 6). In addition, superposition of the
active-site clefts of ASL, fumarase C, and an inactive
mutant (H162N) of δ(II)-crystallin [18] (the isoform of 
δ-crystallin that has argininosuccinate lyase activity) shows
that this putative charge-relay pair is conserved struc-
turally throughout the superfamily (Figure 7). 
In contrast to the catalytic base, which seems to be fixed,
the catalytic acid does not exhibit significant overlap in
sequence or structure for this superfamily of enzymes. In
fact, it is unclear from the literature which residue acts as a
catalytic acid in either δ(II)-crystallin or fumarase C. The
catalytic acid in ASL, His68, is absolutely conserved among
all adenylosuccinate lyases (Figure 6), but not among the
other members of the superfamily. The multiple sequence
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Figure 4
The active-site clefts of ASL, fumarase C, and
δ-crystallin. The residues that make up the
active-site cleft have been excised from the
entire tetramer. The interior of each cleft has
been arbitrarily highlighted to enhance its
appearance. (a) ASL, (b) fumarase C, and
(c) δ-crystallin, all viewed in the same
orientation. (d) δ-Crystallin, rotated 90° about a
vertical axis relative to the orientation in (c). This
figure was generated using RIBBONS [36].
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alignment data predict that His68 of ASL might align with
Glu88 of δ(II)-crystallin, but the 3D structures show that
the two residues fail to superimpose by almost 5 Å. In the
superposition of ASL and δ(II)-crystallin, Arg115 is the
closest in space to His68; Nε of Arg115 is 1.95 Å from Nε2 of
His68 (Figure 7a). In the δ(II)-crystallin mutant structure
with bound argininosuccinate it seems that the Cβ carbon
of argininosuccinate cannot be placed near the catalytic
base such that the leaving nitrogen is close enough to
Glu88 for that residue to act as a catalytic acid. The location
of Arg115 would seem to make this residue a more likely
candidate for the catalytic acid in δ(II)-crystallin, especially
in light of the fact that this residue is essential for catalytic
activity [19]. However, the extremely high pKa of the
guanidinium group, combined with a lack of precedent for
acid catalysis by arginine, makes Arg115 a less certain can-
didate for the catalytic acid. In the superposition of ASL
and fumarase C, Thr100 of fumarase C is close in space to
His68 (Figure 7b), but it would be an unlikely candidate
for the catalytic acid. 
The above data are counterintuitive. As the substrates in all
three reactions consist essentially of a fumarate root with
highly variable leaving groups, one might expect both the
catalytic acid and the catalytic base to be fixed in space for
all three enzymes. The fact that the catalytic acid is not
spatially conserved for the three enzymes implies that the
substrate binds with the fumarate moiety in a different con-
formation in each of the three enzymes. The mechanistic
and evolutionary reasons for this are not clear at this time.
Both adenylosuccinate carboxylates are close enough in
the current model to amide-containing protein residues
(Gln212 and Asn270) to form potential hydrogen bonds.
Both of these residues are absolutely conserved among
the ASLs in the multiple sequence alignment (Figure 6),
but only Asn270 is absolutely conserved among members
of the β-elimination superfamily. After superposition,
Asn116 of δ(II)-crystallin is within 3.5 Å of Gln212 of
ASL (Figure 7a). As it is absolutely required for activity
[19], perhaps Asn116 hydrogen bonds to one of the two
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Figure 5
Manual placement of substrates in the ASL active site.
(a) Adenylosuccinate, and (b) SAICAR. The asterisks denote atoms in
adenylosuccinate that differ from those in SAICAR. The red asterisk
denotes the site of attachment of 2-BDB-TAMP. The residues shown in
the active site are color coded according to the monomer from which
they were derived (same color scheme as Figure 2). (c) Mechanism
whereby ASL is able to complete the insertion of nitrogens at two
different places (square and circle, right-hand panel) in the nucleotide. A
180° rotation must occur in the indicated bond after fumarate is
eliminated in the first ASL reaction (left-hand panel) in order to allow ring
closure by IMP cyclohydrase. The center panel shows a potential
mechanism for the concerted catalysis carried out by ASL (adapted from
[37] Figure 6). Parts (a) and (b) of this figure were generated using
RIBBONS [36].
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carboxylates of argininosuccinate. The multiple sequence
alignment data fail to predict this structural alignment.
Similar behavior is observed for the other potential
carboxylate-binding residue. Asn291 of δ(II)-crystallin
resides close to Asn270 of ASL, but does not overlap it
(Figure 7a). In contrast, Asn326 and Asn141 of fumarase
C superpose well with Asn270 and Gln212 of ASL
(Figure 7b). In the co-crystal structure of fumarase C with
bound citrate, both of these residues interact with car-
boxylate groups [20]. 
In addition, a portion of the signature-sequence loop,
which is not visible in this structure, looks as if it would
have to pass over the area that contains the phosphate in
order to connect with the rest of the loop. This missing
region has the sequence RKGQRGS (in single-letter
amino acid code). These residues could provide sufficient
positive charge and polar interactions to stabilize the phos-
phate in this area of the active site.
Overall, the active-site architecture of ASL matches that
of fumarase C more closely than that of δ(II)-crystallin.
However, comparison of the active site of ASL with those
of both enzymes provides information regarding which
residues of ASL are important for substrate binding and
catalysis. These data implicate the same residues as those
identified by the manual placement of adenylosuccinate
into the active site of ASL.
As ASL catalyzes the conversion of SAICAR to AICAR as
well as adenylosuccinate to AMP, one must consider how
ASL accommodates both substrates. In fact, it seems that
no special adaptations by the protein are necessary. As the
carbon to which the succinyl moiety is attached in
SAICAR is able to rotate prior to ring closure, the enzyme
can bind SAICAR with its succinyl moiety in the same ori-
entation as in the adenylosuccinate reaction (Figure 5b).
The positions at which adenylosuccinate and SAICAR
differ are labeled with asterisks in Figure 5a. As these
atoms make no specific contacts to the enzyme in the
model of the ASL–adenylosuccinate complex, it is proba-
ble that their presence or absence would have a minimal
effect on substrate affinity. The ability of the amide
moiety (left by the first reaction) to rotate allows ASL to
participate in the insertion of a nitrogen at two different
positions in the nucleotide, one before and one after ring
closure (Figure 5c). This unusual versatility makes ASL
unique among the β-elimination superfamily of enzymes.
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Figure 6
Multiple sequence alignment of the superfamily of enzymes that
catalyze β-elimination reactions. Sections that exhibit significant
overlap have been excised from the entire alignment. Residues that are
conserved in at least 70% of the sequences in the superfamily are
highlighted in black. Residues that are conserved in at least 70% of
the ASL sequences are highlighted in gray. Thr404 of T. maritima ASL
and the corresponding residues from other ASLs are shown boxed.
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The S413P human ASL mutation implicated in autism
Of the human ASL mutations associated with disease
states, the S413P mutation has been studied most carefully
[13]. This mutation destabilizes ASL, making it more sus-
ceptible to proteolytic degradation. The S413P human
mutation is mapped to two different residues in T. maritima
ASL, Thr404 or Glu406, by two different sequence–struc-
ture comparison techniques (see the Materials and methods
section; Figure 8). Glu406 resides at the base of helix 20,
whereas Thr404 lies on the transition between helices 19
and 20. The multiple sequence alignment data predict that
this residue will map to Thr404. Based on the sequences
used for the multiple alignment (with the exception of
Pyrobaculum aerophilum), the residue at this position is one
of four polar amino acids (serine, glutamine, aspartate or
threonine). Introduction of a proline residue at either of
these positions could affect the position of the two helices
at the C terminus (21 and 22), which pack tightly against
helices 9 and 16 and strand 2 of domain 2. If the close con-
tacts between these helices and the core were strained, the
entire C terminus could be left vulnerable to proteolytic
attack. The effect would be especially deleterious in the
human enzyme because, according to the sequence–struc-
ture alignments, the C-terminal extension would continue
for another 22 residues beyond the T. maritima ASL C ter-
minus. Thus, the target for proteolysis would be larger and
the number of favorable contacts lost would be greater. The
conclusions drawn from these sequence–structure align-
ments are consistent with the finding that the S413P muta-
tion associated with autism results in a catalytically
competent but structurally less stable version of ASL. 
Biological implications
Adenylosuccinate lyase (ASL) catalyzes two separate
reactions in the de novo purine biosynthetic pathway,
one of which affects the conversion of adenylosuccinate
to AMP. Remarkably, using a single active site, ASL
participates in the insertion of a nitrogen at two different
positions in AMP. In addition, ASL participates in the
purine nucleotide cycle, a three-enzyme functional unit
that tightly regulates cellular metabolism by controlling
the amounts of free AMP and fumarate. Because of its
pivotal metabolic role, mutations in human ASL can
cause, among other defects, severe mental retardation.
The three-dimensional structure of Thermus maritima
ASL permits us to construct a model for substrate
binding that is consistent with the biochemical evidence
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Figure 7
Stereoview of the superimposed active sites
of ASL, fumarase C, and δ-crystallin. (a) ASL
and δ-crystallin. The ASL active-site residues
are colored black, and the δ-crystallin active-
site residues are colored red. (b) ASL and
fumarase C. The ASL active-site residues are
colored black, and the fumarase C active-site
residues are colored red. This figure was
generated using RIBBONS [36].
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for His68 acting as the catalytic acid and His141 acting
as the catalytic base. In addition, the other residues
implicated by this modeling are both highly conserved in
a multiple sequence alignment of ASLs and are some-
what structurally conserved among diverse members of
the β-elimination superfamily. We also propose a model
for the action of ASL on both adenylosuccinate 
and 5-aminoimidazole-(N-succinylocarboxamide) ribotide
(SAICAR) at different steps in the same metabolic
pathway. In this model, a single 180º bond rotation in
the substrate allows ASL to operate on atoms at two dif-
ferent positions in the nucleotide. 
Comparison of ASL with fumarase C and δ-crystallin
indicates that ASL has evolved a much deeper binding
cleft to accommodate its large substrates. Despite the
similar chemistry performed by these three enzymes,
structure superposition of ASL, fumarase C, and δ-crys-
tallin demonstrates that the active-site architecture is
only partially conserved. 
The modeling of the pathogenic S413P human ASL
mutation shows that it destabilizes the enzyme by disrupt-
ing the C-terminal extension. The observation that this
and other mutations have such severe effects in humans
reflect the important role ASL plays in maintaining the
tight regulation of cellular metabolism. The crystal struc-
ture provides a basis for further examination of this and
other pathogenic ASL mutants at the molecular level.
Materials and methods
Plasmid construction
The sequence for the T. maritima ASL was pieced together from the
incomplete genome of T. maritima. The sequence from the initiating
methionine codon to the first stop codon encountered is of identical
length (431 amino acids) to the B. subtilis ASL and shares 51.3%
sequence identity. Using this sequence as a guide we designed poly-
merase chain reaction (PCR) amplification primers for the sense (TCGA-
GATAGGATCC1ATGGTAGAAAGGTATTCG) and antisense (CGC-
GTCAAGCTTTCACTCCTTTTCAAAGCG) strands. The gene was ampli-
fied with the enzyme Pfu polymerase using these primers and T. maritima
genomic DNA. The resulting PCR product was then subjected to diges-
tion with BamHI and Hind III and subcloned into the vector pT7-7.
Expression, purification, and crystallization of selenomethionyl
T. maritima ASL (SeTASL)
Selenomethionine incorporation involved the use of the normal
Escherichia coli BL21(DE3) cells used to grow the wild-type protein
rather than an auxotroph. In this method, only those amino acids that
inhibit methionine biosynthesis are added, along with selenomethionine,
to the media [21]. A single colony from a fresh transformation of pT7-7-
TASL and pSBETa [22] (to account for rare arginine codons) into
BL21(DE3) cells was inoculated into 1 l of a modified M9 media [21]
containing 100 µg/ml ampicillin and 30 µg/ml kanamycin and L-methion-
ine instead of L-selenomethionine. This culture was allowed to grow
overnight until it reached an OD600 of 0.74, at which time the cells were
centrifuged at 8000 × g for 5min and the media carefully decanted from
the cell pellets. Half of the cells were then resuspended into media iden-
tical to the above, but with L-selenomethionine substituted for L-methion-
ine. The cells were allowed to double once, at which time they were
induced by addition of isopropyl-β-D-thiogalactoside (IPTG) to a final
concentration of 1 mM for 3h. The cells were then centrifuged at
8000 × g for 5min and stored at –20ºC. Cell pellets were resuspended
in buffer A (20 mM Tris pH 8.8, 0.02% (w/v) NaN3; 40 ml per 1 l cell
culture) plus 10 mM benzamidine-HCl, 5 mM L-methionine, and ~10 mg
DNase and passed twice through a French press at 1100 psi. Following
lysis, the cell debris was removed by centrifugation at 37,000 × g for
30 min. β-Mercaptoethanol was added to the supernatant to a final con-
centration of 30 mM and the supernatant was subjected to heat denatu-
ration at 80ºC for 5 min. The precipitated E. coli proteins were removed
by centrifugation at 21,000 × g for 60min. The resulting supernatant
was further purified using a Q-sepharose anion-exchange column (40 ml
bed volume). The fractions containing T. maritima ASL (TASL) were
pooled and dialyzed overnight against 10 mM Tris pH 8.8, 1 mM EDTA,
0.5 mM benzamidine-HCl, and 0.02% (w/v) NaN3. The protein was then
concentrated using a Millipore Ultrafree-15 concentrating device with a
100 kDa cutoff to a final concentration of 12.5 mg/ml. Crystals suitable
for X-ray analysis were grown via hanging-drop vapor diffusion at 18°C.
The best crystals were achieved by mixing 2 ml of protein at 12.5 mg/ml
with 1 ml of reservoir solution (0.1 M sodium acetate pH 4.5, 0.1–0.5%
PEG4000, 6% (v/v) glycerol, 1 mM β-mercaptoethanol, 0.02% (w/v)
NaN3). Crystals appeared within two days and reached a maximal size
of 0.3 × 0.2 × 0.05 mm within two weeks. The optimal cryoprotectant for
the selenomethionyl crystals was a solution containing 0.1 M NaAcetate
pH 4.5, 1% (w/v) PEG4000, 1 mM β-mercaptoethanol, and 35% (v/v)
glycerol. The crystals are C-centered orthorhombic (C2221) with cell
dimensions a = 120.81 Å, b = 126.75 Å, c = 169.00 Å, and contain a
dimer in the asymmetric unit.
Data collection, MAD phasing, and density modification
Data for a four-wavelength selenomethionyl MAD experiment were col-
lected at BNL beamline X8C using the ADSC Quantum-4 charge
coupled device (CCD) detector. The crystals diffracted well, and for
each wavelength gave useful data to 1.8 Å. The data for all four
datasets were processed using the DENZO/SCALEPACK [23] 
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Figure 8
Mapping of the S413P human ASL mutation to the T. maritima ASL
structure. The residue singled out by directional profiles (Asp406) is
colored green. The residue singled out by the extensible threading
calculator (ETC) method (Thr404) is colored cyan. The C-terminal
extension is colored red. This figure was generated using RIBBONS [36].
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software package. The data collection statistics are presented in
Table 1. Solution of the heavy-atom substructure was accomplished
using the program Shake-and-Bake (version 2.0) [24]. From the
∆Eanomalous coefficients for the peak wavelength, Shake-and-Bake con-
verged readily to a solution for all 20 selenium atoms that were
expected to be ordered in the asymmetric unit (the N-terminal methio-
nine was assumed to be disordered). The heavy-atom sites were
refined and the phases calculated using the program SHARP [25]. As
the second remote wavelength had the highest f′, and would therefore
give the largest dispersive signal for phasing, it was chosen to be the
native dataset. Following heavy-atom refinement using all 20 selenium
sites and data from 50–1.8 Å, the overall figure of merit was 0.6629.
Density modification involved molecular averaging, solvent flattening,
and histogram matching using the program DM [26]. After this proce-
dure, the overall figure of merit was 0.896 and the map was of excel-
lent quality (Figure 9a).
Refinement of selenomethionyl T. maritima ASL
All model building was carried out with the program O [27]. Refine-
ment was performed with the program REFMAC [28] using the phase-
modified maximum-likelihood target function (mlhl) and geometric
restraints. The exponential bulk scaling solvent correction was used,
and individual isotropic displacement parameters (also known as tem-
perature factors) were refined along with atomic positions. The two
molecules in the asymmetric unit were refined with tight noncrystallo-
graphic restraints. After several rounds of model building and addition
of waters, the Rfree was 21.90% and the Rcryst was 19.31%. The next
round of refinement included refinement of restrained atomic
anisotropic temperature factors [29]. Analysis of the anisotropy by the
program PARVATI [30] demonstrated that the overall correction for
both protein and solvent was modest (0.802), with only a few atoms
displaying a high degree of anisotropy. However, the geometry
improved significantly as Rcryst and Rfree decreased. After making some
corrections and refining atomic anisotropic displacement parameters,
the final Rfree was 20.70% and the Rcryst was 17.87%. The final model
contains, per monomer, residues 2–257 and 263–430. Residue 1,
residues 258–262, and residue 431 are not visible in the structure
(Figure 9b). Twenty-one sidechains in each monomer have been trun-
cated to alanine. In addition, Glu16 is truncated after Cδ, Glu45 is trun-
cated after Cγ, and Lys343 is truncated after Cε. Analysis by the
program ERRAT [31] shows that 99.2% of the residues for the
SeTASL dimer are within the 95% confidence limit, indicating that the
non-bonded interactions adhere closely to the predicted distribution. In
addition, the Ramachandran plot (PROCHECK [32]) shows that
94.1% of non-glycine and non-proline residues are in the most-favored
regions. A more detailed description of the refinement statistics is pre-
sented in Table 1.
Native crystallization, data collection, and structure refinement
Crystals of wild-type TASL were grown via hanging-drop vapor diffu-
sion at high pH by mixing equal volumes of protein (12.5 mg/ml) and
reservoir solution (0.1 M Bicine pH 9.0, 5 mM AMP, 1.8 M (NH4)2SO4,
and 0.02% (w/v) NaN3). The crystals were incubated briefly in the
above solution (1 M (NH4)2SO4) plus 40% (v/v) glycerol and flash-
cooled in liquid nitrogen. Complete data to 2.3 Å were collected at
BNL beamline X8C using the ADSC Quantum-4 CCD detector. The
crystal was of the same form as both wild-type low pH and SeTASL,
but with slightly different cell dimensions (a = 120.50 Å, b = 126.21 Å,
and c = 169.05 Å). The data were processed using the
DENZO/SCALEPACK software package (Table 1). Structure solution
involved rigid-body refinement of the SeTASL model into the high-pH
TASL cell using the program CNS. After this rigid-body refinement,
atomic positions and individual temperature factors were refined simul-
taneously using REFMAC with the maximum-likelihood target function
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Table 1
Summary of crystallographic data.
Data sets Low remote (native) High remote Peak Inflection High-pH native
Data collection statistics
Wavelength (Å) λ1 = 1.000 λ2 = 0.917 λ3 = 0.9786 λ4 = 0.9788 λ = 0.908
Resolution (Å) 1.8 1.8 1.8 1.8 2.3
Completeness (%)
overall (final shell) 97.8 (84.1) 99.2 (93.5) 98.2 (86.8) 98.5 (89.0) 99.7 (98.8)
Rmerge* (final shell) 0.059 (0.295) 0.059 (0.278) 0.055 (0.233) 0.063 (0.324) 0.085 (0.263)
Phasing statistics
Phasing power
acentric† —/— 1.11/3.06 5.59/4.76 5.58/4.76
centric — 0.91 3.54 3.54
Rcullis‡
acentric† —/— 0.63/0.71 0.28/0.45 0.28/0.45
centric — 0.71 0.32 0.32
Figure of merit 0.761
Refinement statistics
Resolution range (Å) 50.0–1.8 50.0–2.3
Number of protein atoms 6734 6416
Number of solvent atoms 693 412
Rcryst (Rfree)§ 0.179 (0.207) 0.199 (0.230)
Average B factor (protein) 19.67 22.99
Average B factor (solvent) 32.24 27.69
Rmsds
Bonds (Å) 0.015 0.012
Angles (°) 2.64 2.84
*Rmerge = Σhkl(Σi|Ihkl,i—〈Ihkl〉|)/Σhkl 〈Ihkl〉. †Phasing power and Rcullis statistics for acentric reflections are presented as isomorphous/anomalous.
‡Rcullis = (Σhkl || FPH ± FP | –FH,calc |)/Σhkl | FPH–FP |. §Rcryst= Σhkl ||Fobs| – k |Fcalc||/Σhkl| Fobs|.
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for amplitudes (mlf) and the exponential bulk-solvent and anisotropic
overall temperature factor corrections. In addition, the two molecules
were tightly restrained to obey the observed noncrystallographic sym-
metry (NCS). The final model contains, per monomer, residues 2–256
and 263–430. Residues 1, 257–262, and 431 are not visible in this
structure. In addition, 23 residues have been truncated to alanine. A
more detailed description of the refinement statistics is presented in
Table 1. The final Ramachandran and ERRAT analyses show excellent
adherence to theoretical geometric parameters and non-bonded
contact distributions.
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Figure 9
The crystal structure of T. maritima ASL.
(a) Stereo diagram of experimental electron
density for residues 213–229 after NCS
averaging, solvent flattening, and histogram
matching with the program DM. The map is
contoured at 1.5σ. (b) Stereo diagram of a Cα
trace of the ASL monomer with every 40th
residue numbered. Part (a) of this figure was
generated using RIBBONS [36]. Part (b) of this
figure was generated using MOLSCRIPT [38].
st8207.qxd  02/29/2000  12:11  Page 173
Structural and multiple sequence alignment between
members of the β-elimination superfamily
3D structure alignments between members of the β-elimination superfam-
ily were performed using the program SFIT (E Marcotte, personal commu-
nication). Briefly, the program first calculates, for both structures (target
and probe), a distance matrix for each Cα in which the pairwise distances
involving that Cα and its ten nearest neighbors are tabulated. Subse-
quently, the distance matrices for the target and probe are compared
pairwise over all residue positions. The resulting similarity scores are used
to construct a similarity matrix for the two proteins. The optimal structure
alignment is the optimal path through this similarity matrix as determined
by the Smith–Waterman algorithm [33]. All multiple amino acid sequence
alignments were performed using the program CLUSTALW [34].
Sequence–structure alignment of the human ASL sequence
to the T. maritima ASL structure
In order to construct a reasonable sequence–structure alignment between
human and T. maritima ASLs, two variations of the 3D–1D profile method
[35] were employed. The first method, Directional Profiles (P Mallick, per-
sonal communication), characterizes each residue in terms of the local dis-
tribution of atoms around its Cα. The second method, the extensible
threading calculator (ETC) (P Mallick, personal communication), simultane-
ously characterizes each residue in terms of an environmental profile
similar to that described by Bowie et al. [35], and a Lennard–Jones style
contact potential. As there is a chain break in the T. maritima ASL struc-
ture, the two parts of the monomer were treated as separate alignments.
Accession numbers
The coordinates for both the selenomethionine-substituted ASL and
the native ASL have been deposited in the Protein Data Bank with
accession numbers 1c3c and 1c3u, respectively.
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